Newpharma SA
14.3 FTEThe score of Newpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2024 → 2026: Revenue -4 % Equity -20 % Total assets +21 % Headcount (avg FTE) -3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Newpharma's annual accounts
| 2026 | 2025 | 2024 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €218.2m | ||||
| Net result | −711,789 € | ||||
| Equity | €1.81m | ||||
| Cash | €1.64m | ||||
| EBITDA | −451,905 € | ||||
| Total assets | €36.6m |
Filed annual accounts
- Year ended 31 Mar 2026filed on 21 Sep 2026
- Year ended 31 Mar 2025filed on 25 Sep 2025
- Year ended 31 Mar 2024filed on 19 Sep 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
Newpharma's financial analysis
- Solvency4.9%sector median: 31.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Newpharma
Newpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0838.666.156
- VAT number
- BE0838666156
- Peppol
- Registered · 0208:0838666156 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 22 Aug 2011
- Registered office
- 4020 Liège
- Size
- Small · 14.3 FTE
- Latest accounts
- 2026 · filed on 21 Sep 2026
- Activity
- Other non-specialised retail sale (NACE 47120)
Newpharma (SA) has been based in Liège since 2011, active in: other non-specialised retail sale. For 2026, it reports revenue of €218.2m, a net loss of 711,789 € and equity of €1.81m. With 14.3 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 4.9%, below the median of its sector (31.1%).
Companies similar to Newpharma
Companies in the same business, of comparable size and area, outside its group.
- BePharBel Manufacturing Manufacture of basic pharmaceutical products Courcelles · balance sheet €27.4m
- Pharmacies Populaires DE Verviers ET Arrondissement Retail sale of pharmaceutical products Thimister-Clermont · balance sheet €73.8m
- DI Retail sale of other new goods Anderlecht · balance sheet €39.0m
- Pharma Force Retail sale of pharmaceutical products Ghent · balance sheet €15.7m
- Pharmacie populaire La Sauvegarde Retail sale of pharmaceutical products Soumagne · balance sheet €5.64m
- MOES Retail sale of pharmaceutical products Heers · balance sheet €16.4m
- L'Economie Populaire Retail sale of pharmaceutical products Ciney · balance sheet €114.7m
- MEDI-MARKET Parapharmacies Retail sale of pharmaceutical products Evere · balance sheet €171.3m
Frequently asked questions about Newpharma
What is the revenue of Newpharma?
According to the 2026 annual accounts filed with the NBB, the revenue of Newpharma amounts to 218,188,628 €.
What is the VAT number of Newpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0838666156 for Newpharma, if the company is VAT-registered. Its company number (CBE) is 0838.666.156.
Where is the registered office of Newpharma?
According to the CBE register, the registered office of Newpharma is in 4020 Liège.
What is the equity of Newpharma?
At the close of the 2026 financial year, the equity of Newpharma amounts to 1,805,330 €, a solvency of 4.9% of total assets.
How many people work at Newpharma?
14.3 full-time equivalents on average according to the 2026 social balance sheet.
Who manages Newpharma?
The register lists 6 active mandates at Newpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Newpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →